Aarti Drugs Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Aarti Drugs Limited
Symbol
AARTIDRUGS
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Additional Disclosure Date
29-Apr-2026
Additional Disclosure Designation
CFO
Additional Disclosure Name Of Signatory
Adhish Prakash Patil
Additional Disclosure Place
Mumbai
Advertisements As Per Regulation471
Yes
Affirmations
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Not Applicable
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance Status
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
29-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.aartidrugs.com/reports-fillings-annual-return
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.aartidrugs.com/reports-fillings-concall-transcript
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.aartidrugs.com/shareholders-information-notice
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.aartidrugs.com/corporate-governance-policies-and-related-documents
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.aartidrugs.com/corporate-governance-policies-and-related-documents
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.aartidrugs.com/reports-fillings-subsidiary-financials
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.aartidrugs.com/reports-fillings-credit-ratings
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.aartidrugs.com/about#aboutUs
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.aartidrugs.com/corporate-governance-policies-and-related-documents
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.aartidrugs.com/reports-fillings-quarterly-reports
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.aartidrugs.com/corporate-governance-policies-and-related-documents
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.aartidrugs.com/corporate-governance-policies-and-related-documents
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.aartidrugs.com/shareholders-information-shareholding-pattern
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
Yes
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.aartidrugs.com/corporate-governance-disclosures-under-regulation
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.aartidrugs.com/shareholders-information-stock-information
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.aartidrugs.com/shareholders-information-notice
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.aartidrugs.com/corporate-governance-moa-aoa
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
1. https://www.aartidrugs.com/shareholders-information-notice 2. https://www.aartidrugs.com/reports-fillings-investor-presentation
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.aartidrugs.com/reports-fillings-annual-secretarial-compliance-report
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE767A01016
Market Capitalisation As Per Immediate Previous Financial Year
Top 1000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Rushikesh Deole
Name Of Signatory Affirmations
Rushikesh Deole
Name Of Signatory For Annual Affirmations
Rushikesh Deole
Name Of Signatory For Quartely Affirmations
Rushikesh Deole
Name Of The Company
AARTI DRUGS LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
a00006
Scrip Code
524348
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
AARTIDRUGS
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Any Guarantee Or Comfort Letter Of KM Ps Or Any Other Entity Controlled By Them
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of Promoter Group Or Any Other Entity Controlled By Them
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of Promoter Or Any Other Entity Controlled By Them
Not Applicable
Type Of Company
Equity
Type Of Security Of KM Ps Or Any Other Entity Controlled By Them
Not Applicable
Type Of Security Of Promoter Group Or Any Other Entity Controlled By Them
Not Applicable
Type Of Security Of Promoter Or Any Other Entity Controlled By Them
Not Applicable
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
Yes

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
Yes
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrPrakash Moreshwar Pati******00005618Executive DirectorChairpersonCEO-MD16-Aug-1947NoActiveNot Applicable05-Jan-198501-Jun-20221010
2MrRashesh Chandrakant Gogri******00066291Executive DirectorNot ApplicableMD03-Jun-1974NoActiveNot Applicable16-Aug-201231-Oct-20223030
3MrHarshit Manilal Savla******00005340Executive DirectorNot ApplicableMD19-Nov-1962NoActiveNot Applicable02-Jan-198724-Sep-20251010
4MrHarit Pragji Shah******00005501Executive DirectorNot Applicable12-Oct-1963NoActiveNot Applicable15-Sep-199526-Sep-20231010
5MrUday Moreshwar Patil******01186406Executive DirectorNot Applicable03-Jun-1963NoActiveNot Applicable18-Oct-200004-Aug-20221000
6MrNarendra Jagannath Salvi******00299202Non-Executive - Non Independent DirectorNot Applicable16-Aug-1964NoActiveNot Applicable25-Aug-202020-Sep-20242030
7MrAnkit Vikram Paleja******06975564Non-Executive - Independent DirectorNot Applicable25-Sep-1983NoActiveNot Applicable13-Oct-202113-Oct-202453.182232
8MrBhaskar Narayan Thorat******01293824Non-Executive - Independent DirectorNot Applicable23-May-1965NoActiveNot Applicable09-May-202209-May-202546.221100
9MrsNeha Rajen Gada******01642373Non-Executive - Independent DirectorNot Applicable22-Mar-1976NoActiveNot Applicable09-May-202209-May-202546.224491
10MrHasmukh Bhavanji Dedhia******07510925Non-Executive - Independent DirectorNot Applicable21-Jun-1955NoActiveNot Applicable29-Mar-202424.022231
11MrAjit Eledath Venugopalan******09439069Non-Executive - Independent DirectorNot Applicable29-Aug-1963NoActiveNot Applicable29-Mar-202424.021120
12MrSandeep Madhusudan Joshi******00516409Non-Executive - Independent DirectorNot Applicable01-Jan-1961NoActiveNot Applicable29-Mar-202424.021100

Committee Disclosures

Entry CompComit100
Date of Appointment
01-Apr-2024
Entry CompComit101
Date of Appointment
01-Apr-2024
Entry CompComit102
Date of Appointment
15-May-2020
Entry CompComit103
Date of Appointment
15-May-2020
Entry CompComit122
Date of Appointment
01-Apr-2024
Entry CompComit123
Date of Appointment
04-Apr-2014
Entry CompComit124
Date of Appointment
04-Apr-2014
Entry CompComit14
Date of Appointment
01-Apr-2024
Entry CompComit15
Date of Appointment
01-Apr-2022
Entry CompComit16
Date of Appointment
01-Apr-2024
Entry CompComit17
Date of Appointment
01-Apr-2024
Entry CompComit18
Date of Appointment
30-Jul-2007
Entry CompComit19
Date of Appointment
31-Oct-2012
Entry CompComit41
Date of Appointment
01-Apr-2024
Entry CompComit42
Date of Appointment
01-Apr-2024
Entry CompComit43
Date of Appointment
01-Apr-2024
Entry CompComit44
Date of Appointment
30-Jul-2007
Entry CompComit68
Date of Appointment
01-Apr-2024
Entry CompComit69
Date of Appointment
01-Apr-2024
Entry CompComit70
Date of Appointment
18-Apr-2001
Entry CompComit71
Date of Appointment
30-Jul-2007
Entry CompComit95
Date of Appointment
15-May-2020
Entry CompComit96
Date of Appointment
15-May-2020
Entry CompComit97
Date of Appointment
15-May-2020
Entry CompComit98
Date of Appointment
15-May-2020
Entry CompComit99
Date of Appointment
15-May-2020
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.aartidrugs.com/corporate-governance-committees-of-board-of-directors
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
07510925
Member Name
Hasmukh Bhavanji Dedhia
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
06975564
Member Name
Ankit Vikram Paleja
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
01642373
Member Name
Neha Rajen Gada
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
09439069
Member Name
Ajit Eledath Venugopalan
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00005618
Member Name
Prakash Moreshwar Pati
Position
Executive Director

Audit Committee

Additional Position
Member
Director DIN
00066291
Member Name
Rashesh Chandrakant Gogri
Position
Executive Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
01293824
Member Name
Bhaskar Narayan Thorat
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00005618
Member Name
Prakash Moreshwar Pati
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00066291
Member Name
Rashesh Chandrakant Gogri
Position
Executive Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
01642373
Member Name
Neha Rajen Gada
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
01293824
Member Name
Bhaskar Narayan Thorat
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
06975564
Member Name
Ankit Vikram Paleja
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00005618
Member Name
Prakash Moreshwar Pati
Position
Executive Director

Nomination and remuneration committee

Other Committee

Additional Position
Chairperson
Director DIN
00005618
Member Name
Prakash Moreshwar Pati
Name Of Other Committee
Finance and Investment Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
00066291
Member Name
Rashesh Chandrakant Gogri
Name Of Other Committee
Finance and Investment Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
00005501
Member Name
Harit Pragji Shah
Name Of Other Committee
Finance and Investment Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
00005340
Member Name
Harshit Manilal Savla
Name Of Other Committee
Finance and Investment Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
01186406
Member Name
Uday Moreshwar Patil
Name Of Other Committee
Finance and Investment Committee
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
01293824
Member Name
Bhaskar Narayan Thorat
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
06975564
Member Name
Ankit Vikram Paleja
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
Adhish Prakash Patil
Notes
Shri Adhish Prakash Patil is not a member of the Board so his DIN is not mentioned.
Position
Chief Financial Officer

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
Dhanaji Laxman Kakade
Notes
Shri Dhanaji Laxman Kakade is not a member of the Board so his DIN is not mentioned.
Position
Vice President Technical

Risk Management Committee

Additional Position
Chairperson
Director DIN
00005618
Member Name
Prakash Moreshwar Pati
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00066291
Member Name
Rashesh Chandrakant Gogri
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00005501
Member Name
Harit Pragji Shah
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00005340
Member Name
Harshit Manilal Savla
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
01186406
Member Name
Uday Moreshwar Patil
Position
Executive Director

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
06975564
Member Name
Ankit Vikram Paleja
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00299202
Member Name
Narendra Jagannath Salvi
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00005340
Member Name
Harshit Manilal Savla
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00005501
Member Name
Harit Pragji Shah
Position
Executive Director
Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
07-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
12
Number Of Independent Directors Attending The Meeting
6
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
03-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
87
Number Of Directors Present In Meeting Of Board Of Directors
11
Number Of Independent Directors Attending The Meeting
6
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
28-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
24
Number Of Directors Present In Meeting Of Board Of Directors
9
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
07-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
6
Number Of Independent Director Attending Meeting Of Committee
4
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
6
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
03-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
87
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
6
Number Of Independent Director Attending Meeting Of Committee
4
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
6
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
23-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
47
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
6
Number Of Independent Director Attending Meeting Of Committee
4
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
6
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
03-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
03-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
5
Number Of Independent Director Attending Meeting Of Committee
0
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
23-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
47
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
7
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
7
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.aartidrugs.com/shareholders-information-stock-information
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.aartidrugs.com/shareholders-information-stock-information
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
3
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
3
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Entry D_AcquisitionShares1
Percentage Of Shares Or Voting Rights Acquired During The Quarter
1
Entry D_AcquisitionShares2
Percentage Of Shares Or Voting Rights Acquired During The Quarter
0
Entry I_AcquisitionShares_PY1
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0
Entry I_AcquisitionShares_PY2
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry I_AcquisitionShares1
Date Of Acquisition
27-Feb-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Tripharma Chile SpA
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry I_AcquisitionShares2
Date Of Acquisition
16-Mar-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Pinnacle Life Science Private Limited
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry MainD
Any Other Information For Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Explanatory Text Block
Note for Sr.No. 1: our subsidiary i.e. Pinnacle Chile SpA, has incorporated an overseas wholly owned subsidiary in the name of "Tripharma Chlie SpA". The Incorporated Company is a Step-Down subsidiary of Aarti Drugs Limited. The said information has been communication to the Stock Exchanges vide intimation dated March 2, 2026. Note for Sr. No. 2: The Company has invested Rs. 10 Crores by way of subscription to the rights issue of equity shares of its wholly owned subsidiary, Pinnacle Life Science Private Limited (PLSPL). Post allotment of the shares, PLSPL continues to remain a wholly owned subsidiary of the Company. The said information has been communication to the Stock Exchanges vide intimation dated March 7, 2026
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The matter has been challenged by the GST Department before the Hon’ble Supreme Court of India by way of a Special Leave Petition (Civil), against the judgment and order dated October 6, 2025 passed by the Hon’ble High Court in favour of the Company, wherein the order issued by the CGST & Central Excise Authorities was set aside. The Company has duly lodged a Caveat Petition in the matter.
Date of Initiation
03-Aug-2024
Opposing Party
Commissioner of CGST & C.Ex
Status (Previous Disclosure)
On October 6, 2025, the Company received the order passed by the Hon'ble High Court allowing the writ petition filed by the Company and setting aside the order issued by CGST & C.Ex. Authority
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
With respect to the GST related dispute as mentioned in the previous quarter: 1. An appeal against the Order pertaining to FY 2018–19 has been duly filed. 2. The GST Dept. has passed an Order in Form DRC-07 for FY 2019-20 , against which the filing of an appeal is currently under process.
Date of Initiation
28-Jan-2025
Opposing Party
Office of Joint Commissioner of State Tax, Investigation-B, Mumbai
Status (Previous Disclosure)
With respect to the GST related dispute as mentioned in the previous quarter: 1. The Company have received the order passed by Assistant Commissioner of State Tax in Form DRC-07 amounting to Rs. 2,00,41,296/- for the financial year 2018-19. The Company is in process for filing an appeal before the appropriate authority. 2. During Q3 FY26, the Company received the Show Cause Notices for the matters pertaining to financial years 2020-21, 2021-22, 2022-23, 2023-24 and upto June 30 of financial year 2024-25. The reply on these Show Cause Notice are already submitted.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is not applicable to the Company as no fines/ Penalties imposed during the quarter ended March 31, 2026.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No